News > Page 26

• 

  Breakthrough FDA Approval: Iqirvo® for Primary Biliary Cholangitis

  6/11/2024
• 

  Breakthrough MASH Treatment: ASC41 Shows Promising Results in Reducing Liver Fat

  6/11/2024
• 

  FDA Panel's Green Light Brings New Alzheimer’s Treatment Closer to Reality

  6/11/2024
• 

  FDA accelerated approval: New Treatment for Primary Biliary Cholangitis

  6/10/2024
• 

  Breakthrough Epilepsy Treatment: LRP-661 Shows Promising Results in Pre-Clinical Trials

  6/10/2024
• 

  New Hope for Opioid Addiction: INDV-2000 Shows Promise in Early Trials

  6/10/2024
• 

  Breakthrough in Lung Cancer Treatment: TAGRISSO® Receives Priority Review

  6/10/2024
• 

  Octapharma's Innovations for Bleeding Disorder Management to Shine at ISTH 2024

  6/10/2024
• 

  Innovative Biotech Advances: Join Longeveron's Virtual Presentation on Regenerative Medicine

  6/10/2024
• 

  Abbott introduces innovative glucose monitoring solutions for consumers and diabetics

  6/10/2024